Researchers seeking to acquire high-purity Follistatin for laboratory investigation require verifiable analytical testing, strict lot traceability, and consistent peptide synthesis standards. PX1 Research supplies USA-manufactured, research-grade Follistatin peptides backed by lot-specific third-party Certificate of Analysis documentation for in vitro and preclinical research applications.
Researchers seeking to acquire high-purity Follistatin for laboratory investigation require verifiable analytical testing, strict lot traceability, and consistent peptide synthesis standards. PX1 Research supplies USA-manufactured, research-grade Follistatin peptides backed by lot-specific third-party Certificate of Analysis documentation for in vitro and preclinical research applications.
To successfully purchase high-purity research peptides when searching to kopen follistatine peptide online, laboratory personnel must prioritize vendors providing rigorous third-party analytical verification. High-quality Follistatin should be supplied as a lyophilized powder manufactured under strict quality standards, accompanied by lot-specific high-performance liquid chromatography (HPLC) and mass spectrometry (MS) reports confirming purity thresholds above 98%.
PX1 Research delivers reference-grade research peptides directly from United States manufacturing facilities. Every production batch undergoes comprehensive quality control testing—including bacterial endotoxin quantification via Limulus Amebocyte Lysate (LAL) testing—ensuring reliable, reproducible results across cellular assays and animal models.
Follistatin (FST) is an autocrine glycoprotein expressed in nearly all vascularized tissues of higher organisms. Originally identified as an follicle-stimulating hormone (FSH) suppressing substance in porcine follicular fluid, subsequent biochemical characterization established Follistatin as a high-affinity binding protein that neutralizes specific members of the transforming growth factor-beta (TGF-β) superfamily.
Alternative splicing of the primary mRNA transcript yields distinct precursor proteins that undergo differential proteolytic processing. The primary isoforms evaluated in laboratory settings include Follistatin-288 (FST-288), Follistatin-315 (FST-315), and Follistatin-300 (FST-300). In preclinical assays, the terminal carboxyl domain configuration dictates heparin-binding affinity, cell-surface retention, and systemic circulation kinetics.
Researchers investigating local tissue dynamics often utilize FST-288 due to its strong affinity for cell-surface glycosaminoglycans. Conversely, studies examining systemic endocrine signaling frequently select Follistatin-315, which exhibits minimal heparin binding and remains in circulation longer. Understanding these structural variations is vital when choosing specific peptide sequences for targeted in vitro research.
The primary mechanism of action of Follistatin revolves around its ability to irreversibly bind and neutralize specific TGF-β superfamily ligands, most notably Myostatin (Growth Differentiation Factor 8 / GDF-8) and Activin A. Preclinical studies suggest that one Follistatin homodimer or dual monomer complex encapsulates the ligand's receptor-binding epitopes, physically obstructing interaction with Activin type II receptors (ActRIIA and ActRIIB).
By preventing ligand engagement with ActRIIB receptors, Follistatin downregulates the downstream phosphorylation of intracellular SMAD2 and SMAD3 transcription factors. In muscle tissue assays, inhibition of the canonical SMAD2/3 pathway alleviates the transcriptional suppression of myogenin and MyoD, allowing uninhibited skeletal muscle progenitor activation.
Furthermore, in vitro data indicate that Follistatin also neutralizes Activin B and select Bone Morphogenetic Proteins (BMPs, specifically BMP-6 and BMP-7), albeit with varying binding dissociation constants (Kd). Investigating this multi-ligand antagonism provides valuable insight into tissue remodeling, cellular differentiation, and systemic metabolic regulation.
In animal model investigations, transgenic overexpression or exogenous administration of Follistatin peptides has consistently demonstrated pronounced physiological responses. Mouse model studies conducted over the past two decades reveal that disruption of myostatin signaling via Follistatin delivery leads to significant skeletal muscle hypertrophy and hyperplasia without damaging cardiac tissues.
Preclinical studies suggest that in addition to muscular hypertrophy, Follistatin modulation plays a crucial role in adipose tissue phenotype regulation. Rodent models administered Follistatin exhibit increased brown adipose tissue (BAT) recruitment and enhanced uncoupling protein 1 (UCP-1) expression, suggesting potential applications in metabolic research and energy homeostasis studies.
In vitro models utilizing primary myoblast cultures demonstrate that application of recombinant or synthetic Follistatin accelerates myotube fusion and increases total protein synthesis rates. Researchers analyzing these cellular pathways frequently combine Follistatin with other regulatory factors available in our all peptides catalog to map out interactive signaling cascades.
When designing protocols to analyze TGF-β superfamily suppression, researchers often compare Follistatin against other targeted inhibitors. The main compounds evaluated within this functional category include Follistatin-315, Myostatin Propeptide, and GDF-8 Inhibitors.
While Follistatin acts as a broad-spectrum neutralizer targeting both Activin A and Myostatin, Myostatin Propeptide functions as a highly selective inhibitor specific to GDF-8. In rodent comparative models, broader target neutralization by Follistatin results in more pronounced muscle mass accretion, whereas selective propeptide molecules allow researchers to isolate GDF-8-specific signaling pathways without altering Activin-dependent reproductive or inflammatory axes.
Evaluating these distinct pharmacological profiles allows research teams to choose the optimal compound based on their experimental endpoints. Detailed comparative literature and mechanistic breakdowns can be explored through our dedicated research peptide library.
In the peptide synthesis industry, maintaining rigorous chemical characterization is critical. Low-purity reagents introduce unpredictable confounding variables into bioassays, including cellular toxicity from organic synthesis solvents or immunogenic responses triggered by bacterial endotoxins.
When evaluating options to kopen follistatine peptide online, verified laboratories must insist upon batch-specific analytical documentation. High-Performance Liquid Chromatography (RP-HPLC) chromatograms must verify chemical purity exceeding 98.0%, demonstrating the absence of truncated synthesis sequences or diastereomeric impurities. Simultaneously, Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization (ESI) Mass Spectrometry must confirm the precise molecular mass of the peptide sequence.
PX1 Research enforces stringent quality control protocols across every production batch. All peptides undergo testing in ISO 17025 accredited analytical laboratories within the USA, with full Certificate of Analysis (COA) documentation published openly for verification prior to purchase.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes—pose severe hazards to cell cultures and animal models. Even minute endotoxin contamination can trigger toll-like receptor 4 (TLR4) activation, inducing inflammatory cytokine cascades that invalidate experimental measurements.
Standard laboratory specifications for research peptides intended for sensitive cell cultures or in vivo animal administration require endotoxin levels strictly below 10 EU/mg, and often below 0.1 EU/mg for ultra-pure research preparations. PX1 Research conducts Limulus Amebocyte Lysate (LAL) testing on all peptide lots to guarantee compliance with these safety thresholds.
Laboratory personnel should always handle lyophilized peptide vials inside a certified Class II Laminar Flow Bio-Safety Cabinet using sterile, pyrogen-free equipment to prevent environmental contamination during sample preparation.
Lyophilized Follistatin peptides are delivered as stable, freeze-dried cakes or powders. To ensure optimal stability and biological activity upon reconstitution, researchers must strictly follow established laboratory protocols:
1. Centrifugation: Prior to removing the stopper, brief centrifugation (1,000–2,000 x g for 30 seconds) brings any loose lyophilized powder to the bottom of the vial. 2. Solvent Selection: Reconstitute using sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements. Avoid aggressive vortexing, which can induce protein denaturation. 3. Solubilization: Gently swirl or tilt the vial until the peptide is completely dissolved. Allow the solution to sit at room temperature for 5–10 minutes to ensure full hydration. 4. Storage & Aliquoting: Store reconstituted solutions in single-use aliquots at -20°C or -80°C to prevent repeated freeze-thaw cycles, which rapidly degrade peptide integrity. Lyophilized vials should be stored at -20°C protected from light and moisture.
Navigating international peptide suppliers frequently exposes research facilities to risks regarding inconsistent purity, missing documentation, customs delays, and degraded samples due to improper transit conditions. Sourcing directly from a United States manufacturer eliminates these logistical vulnerabilities.
PX1 Research manufactures all research compounds inside domestic, GMP-compliant facilities operating under strict quality management systems. Orders ship directly from fulfillment centers in California and Arizona, utilizing temperature-controlled, expedited logistics to preserve product stability from the lab floor to your facility.
Principal investigators, institutional procurement offices, and commercial research facilities requiring bulk quantities or dedicated supply agreements can establish institutional procurement terms via our wholesale portal.
What purity level is required when looking to kopen follistatine peptide online for laboratory research?
For accurate and reproducible laboratory research, Follistatin peptides should possess an analytical purity of ≥98% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry.
What is the primary difference between Follistatin-288 and Follistatin-315?
Follistatin-288 contains a strong heparin-binding domain that causes it to adhere tightly to local cell-surface glycosaminoglycans, making it ideal for localized tissue studies. Follistatin-315 has a weaker heparin-binding affinity, allowing it to circulate systemically in preclinical models.
How does Follistatin inhibit myostatin at the molecular level?
Follistatin physically binds to Myostatin (GDF-8) molecules, forming an inactive complex that prevents Myostatin from engaging Activin type II receptors (ActRIIA/ActRIIB) and blocking downstream SMAD2/3 signaling.
What analytical testing documentation accompanies PX1 Research peptides?
Every lot supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) containing RP-HPLC chromatograms, Mass Spectrometry mass determination, and LAL bacterial endotoxin test results.
How should lyophilized Follistatin be stored upon arrival at the laboratory?
Lyophilized Follistatin should be stored in a freezer at -20°C or -80°C, protected from light and desiccant-sealed against moisture. Reconstituted aliquots must be stored at -80°C to avoid activity loss from repeated freeze-thaw cycles.
What solvent is recommended for reconstituting Follistatin for in vitro assays?
Sterile bacteriostatic water or sterile PBS (pH 7.4) is typically used for reconstitution depending on the specific cell culture or assay buffer requirements. Avoid vigorous mechanical agitation.
Are PX1 Research compounds approved for human consumption or therapeutic use?
No. All compounds provided by PX1 Research are strictly intended for laboratory research and in vitro or preclinical investigation only. They are not for human or veterinary use, therapy, or clinical trial administration.
What shipping options and origins does PX1 Research utilize?
PX1 Research dispatches orders same-day (Monday through Friday) from domestic fulfillment hubs located in California and Arizona, ensuring fast domestic arrival without international customs clearance hurdles.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.